Spain Neurology Clinical Trials Market Size & Outlook

The neurology clinical trials market in Spain is expected to reach a projected revenue of US$ 324.2 million by 2030. A compound annual growth rate of 6.4% is expected of Spain neurology clinical trials market from 2025 to 2030.
Revenue, 2024 (US$M)
$224.8
Forecast, 2030 (US$M)
$324.2
CAGR, 2025 - 2030
6.4%
Report Coverage
Spain

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Spain neurology clinical trials market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Spain neurology clinical trials market highlights

  • The Spain neurology clinical trials market generated a revenue of USD 224.8 million in 2024 and is expected to reach USD 324.2 million by 2030.
  • The Spain market is expected to grow at a CAGR of 6.4% from 2025 to 2030.
  • In terms of segment, phase iii was the largest revenue generating phase in 2024.
  • Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.


Neurology clinical trials market data book summary

Market revenue in 2024USD 224.8 million
Market revenue in 2030USD 324.2 million
Growth rate6.4% (CAGR from 2025 to 2030)
Largest segmentPhase iii
Fastest growing segmentPhase I
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPhase I, Phase II, Phase III, Phase IV
Key market players worldwideSyneos Health, Icon PLC, AbbVie Inc, GlaxoSmithKline, Aurora Healthcare, Labcorp Drug Development, Pfizer Inc, AstraZeneca PLC, Biogen Inc, Eli Lilly and Co, Alzheon, BDD & Cie, Cognition Health Partners


Other key industry trends

  • In terms of revenue, Spain accounted for 3.9% of the global neurology clinical trials market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, UK neurology clinical trials market is projected to lead the regional market in terms of revenue in 2030.
  • Italy is the fastest growing regional market in Europe and is projected to reach USD 372.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Neurology Clinical Trials Market Companies

Name Profile # Employees HQ Website
Cognition Health Partners View profile 11-50 Panama City Beach, Florida, United States, North America http://cognitionhealthpartners.com
BDD & Cie View profile 11-50 Les Acacias, Geneve, Switzerland, Europe https://www.bdd.ch
Alzheon View profile 11-50 Framingham, Massachusetts, United States, North America http://www.alzheon.com
Aurora Healthcare View profile 1001-5000 Sydney, New South Wales, Australia, Oceania https://aurorahealth.com.au
GlaxoSmithKline View profile 10001+ London, England, United Kingdom, Europe http://www.gsk.com
Syneos Health View profile 1001-5000 Morrisville, North Carolina, United States, North America https://www.syneoshealth.com/
Labcorp Drug Development View profile 10001+ Princeton, New Jersey, United States, North America https://drugdevelopment.labcorp.com
Biogen Inc View profile 7570 225 Binney Street, Cambridge, MA, United States, 02142 https://www.biogen.com
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
Icon PLC View profile 41150 South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 https://www.iconplc.com
Eli Lilly and Co View profile 43000 Lilly Corporate Center, Indianapolis, IN, United States, 46285 https://www.lilly.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com

Spain neurology clinical trials market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neurology clinical trials market will help companies and investors design strategic landscapes.


Phase iii was the largest segment with a revenue share of 45.55% in 2024. Horizon Databook has segmented the Spain neurology clinical trials market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Spain neurology clinical trials market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Spain neurology clinical trials market databook

  • Our clientele includes a mix of neurology clinical trials market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Spain neurology clinical trials market , including forecasts for subscribers. This country databook contains high-level insights into Spain neurology clinical trials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Spain Phase - Neurology Clinical Trials Market size, 2024 - 2030 (US$M)

Spain Neurology Clinical Trials Market Outlook Share, 2024 & 2030 (US$M)

Spain Phase - Neurology Clinical Trials Market size, 2024 - 2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online